Level Biotechnology (3118) — Cash Flow Reinvestment Rate
Level Biotechnology (3118) has a Cash Flow Reinvestment Rate of 0.80x as of September 2025, reinvesting NT$9.45 Million (capex NT$4.44 Million plus investments NT$-5.01 Million) from operating cash flow of NT$11.81 Million. Explore how much does Level Biotechnology reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Level Biotechnology Cash Flow Reinvestment Rate (2017–2024)
Historical reinvestment intensity for Level Biotechnology across 8 annual periods. Also explore balance sheet size of Level Biotechnology for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Level Biotechnology (2017–2024)
Year-by-year capital reinvestment analysis for Level Biotechnology. For live market cap and broader valuation context, see Level Biotechnology (3118) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (TWD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 3.57x | NT$228.80 Million | NT$64.10 Million | NT$223.68 Million | ▲ +1249.9% |
| 2023 | 0.26x | NT$18.57 Million | NT$70.21 Million | NT$7.67 Million | ▲ +1.7% |
| 2022 | 0.26x | NT$16.93 Million | NT$65.07 Million | NT$6.74 Million | ▲ +317.3% |
| 2021 | 0.06x | NT$9.72 Million | NT$155.95 Million | NT$9.15 Million | ▲ +67.0% |
| 2020 | 0.04x | NT$3.11 Million | NT$83.23 Million | NT$2.54 Million | ▲ +36.0% |
| 2019 | 0.03x | NT$2.99 Million | NT$109.02 Million | NT$2.43 Million | ▼ -76.1% |
| 2018 | 0.11x | NT$3.08 Million | NT$26.77 Million | NT$2.51 Million | ▼ -78.3% |
| 2017 | 0.53x | NT$37.79 Million | NT$71.29 Million | NT$10.83 Million | — |